Concepedia

Author

Isabelle Rivière

Memorial Sloan Kettering Cancer Center

Also Known As

I RIVIERE, I Riviere, I Rivière, I. Riviere, I. Rivière, I.C. Riviere, I.C. Rivière, ISABELLE RIVIERE, ISABELLE RIVIÈRE, Isabelle C. Riviere

298

Publications

25.9K

Citations

62

H-Index

91

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell UniversityKettering University
IR

About

Isabelle Rivière is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

47

6.5K

2

Health Sciences

10

10

649

3

Engineering

2

2

83

4

Allergy

2

2

1.3K

5

Natural Sciences

1

1

13

Isabelle Rivière

×

100

Publications

20.1K

Citations

50

H-Index

YearCitations

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Jae H. Park, Isabelle Rivière, Mithat Gönen,

New England Journal of Medicine

2018

2.6K

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila, Isabelle Rivière, Xiuyan Wang,

Science Translational Medicine

2014

2.5K

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière,

Science Translational Medicine

2013

2.1K

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park,

Blood

2011

1.3K

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

John Maher, Renier J. Brentjens, Gertrude Gunset,

Nature Biotechnology

2002

997

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Bianca Santomasso, Jae H. Park, Darin Salloum,

Cancer Discovery

2018

887

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

Renier J. Brentjens, Jean‐Baptiste Latouche, Elmer Santos,

Nature Medicine

2003

655

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu,

Nature

2019

621

Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

Xiao-Song Zhong, Maiko Matsushita, Jason Plotkin,

Molecular Therapy

2009

535

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière,

Cancer Discovery

2021

514

Page 1